Lynx1 Capital Management LP

10% OwnerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Oct 21, 2025
Net Buying
Open-Market Buys
$2.1M
Open-Market Sells
$0
Net Open-Market Flow
$2.1M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2025Buy(P)32K$7.84$253K8.8M
Oct 16, 2025Buy(P)150K$8.86$1.3M8.8M
Oct 15, 2025Buy(P)52K$7.94$409K8.6M
Oct 14, 2025Buy(P)15K$7.59$114K8.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-004499) within minutes of acceptance. Every field above traces to the original document. Verify it directly: